Good Clinical Practice Compliance and the Start-up Company

Posted 01 May 2010 | By

Start-up drug or device companies tend to minimize spending and occasionally to be "penny wise and pound foolish." However, when conducting clinical studies, rules must be followed to ensure the reliability of data. There are many pitfalls a start-up can fall into when first conducting clinical studies. These can be minimized or eliminated by planning the various items for a clinical study before execution and employing skilled and experienced individuals to monitor and audit the studies.


Regulatory Focus newsletters

All the biggest regulatory news and happenings.


Most Viewed Articles